Home > Investors

Investor Relations

Latest Updates

Presentation

Sisram Medical 2024 Annual Results Presentation

Mar 20, 2025
Press Release

Sisram Medical Announces 2024 Annual Results

Mar 19, 2025
Press Release

Sisram Medical Ltd. to Hold FY 2024 Financial Results Conference Call on March 20 at 800 a.m. ET

Mar 13, 2025
Press Release

Sirsram Medical announces NMPA approval for DAXXIFY®, Marking the introduction of the world’s first and only peptide-powered botulinum toxin product to Mainland China

Sep 10, 2024

Financial Reports

View all

24.03.25
2024 Interim Report
06.05.24
2023 Annual Report

Prospectus

Investors’ Relations Contacts

Sisram Medical LTD.

Email: [email protected]

OFEK 15 Building, 18 HaHarash Street, Industrial Park- Caesarea, 3079895, Israel